FORWARD FEATURES CALENDAR

Venture Capital

Go Capital launches EUR60m seed fund

Go Capital has held the first closing of Go Capital Amorçage II, a EUR60 million venture capital fund. The first Go Capital seed fund of EUR57 million was launched in 2012, at the initiative of the Regional Councils of the western France, with the support of Bpifrance (through the French

Vendep Capital launches EUR40m early-stage software venture fund

Vendep Capital has launched a EUR40 million venture find which will invest mainly in Finnish start-ups offering software to B2B customers. The investors are Finnish institutional investors, foundations, family offices and private investors.   By the first closing at the end of April, Vendep Capital Fund II has received capital

Elaia holds first closing of VC fund at EUR115m

Elaia Partners, a Paris-based venture capital firm, has held the initial closing of its new venture capital fund, Elaia Delta Fund, at EUR115 million. This new investment vehicle pursues the fundamental drivers of Elaia Partners’ historical strategy targeting European early-stage digital opportunities based on high disruption and on deep technology.

Moderne Ventures closes USD33m early stage venture fund

Moderne Ventures, a Chicago-based venture capital firm focused on early stage investments in technology companies, has closed its early stage venture investment fund with USD33 million in total commitments. Launched in 2015 by Constance Freedman, Moderne identifies and invests in cutting-edge technology companies who have a shared purpose of modernising

Israeli high-tech capital raising hits USD1.03bn in Q1

In the first quarter of 2017, Israeli high-tech companies raised a total of USD1.03 billion in 155 transactions, a 4 per cent decrease from the USD1.07 billion raised in 165 deals in the previous quarter and 8 per cent lower than the USD1.11 billion raised in 174 deals in Q1

VCTs close financial year with near record high

The 2016/17 financial year is the second most successful on record for the UK venture capital trust (VCT) market with a total of 18 funds coming to market and raising over GBP500 million, a total bettered only in 2004 when VCTs raised GBP779 million.  Law firm Howard Kennedy acted for

Collas Crill advises on healthcare venture fund

Collas Crill has advised on the establishment of BioMedInvest III, BioMedPartners' third Guernsey-domiciled equity venture capital fund, closing at CHF75 million. BioMedInvest III is a collective investment scheme authorised by the Guernsey Financial Services Commission. It is the third Guernsey-domiciled BioMedPartners fund, administered by Louvre Fund Services.   The fund

Nasdaq launches venture investment programme

Nasdaq has launched a venture investment programme, Nasdaq Ventures, dedicated to discovering, investing in and partnering with fintech companies worldwide. The programmes main objective is to identify and collaborate on new technologies and groundbreaking services and solutions which align with Nasdaq's clients' needs and the company's long-term objectives in the

Global VC deal volume drops to lowest level since 2011 in Q1

Venture capital (VC) deal volume continued to fall in Q1 2017 with only 2,716 deals completed globally during the period compared to 3,201 in Q4 2016, according to Venture Pulse Q1 2017 – the quarterly global VC trends report by KPMG Enterprise. Despite the fourth straight quarter of declining deal activity,

SV Health Investors closes science and healthcare fund

SV Health Investors, the venture capital and growth equity firm formerly known as SV Life Sciences, has closed on its sixth flagship fund at its target of USD400 million. SV also manages the Dementia Discovery Fund, plus five other funds that aim to support entrepreneurs and companies that create and

Events

12 November, 2026 – 5:00 pm

Directory Listings